Skip to main content
Erschienen in: Acta Diabetologica 1/2010

01.12.2010 | Original Article

The oxidative stress status in diabetes mellitus and diabetic nephropathy

verfasst von: Hong-zhi Pan, Lin Zhang, Mei-yi Guo, Hong Sui, Hui Li, Wei-hua Wu, Nai-qiang Qu, Mei-hua Liang, Dong Chang

Erschienen in: Acta Diabetologica | Sonderheft 1/2010

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to assess the oxidative stress status in diabetes mellitus (DM) and diabetic nephropathy. The study group comprised 40 control subjects, 40 type 2 DM patients without complications and 37 diabetic nephropathies. Compared with control subjects, superoxide dismutase, glutathione peroxidase, catalase, vitamin C were decreased (P < 0.01). There was a significant increase in serum malondialdehyde (MDA), conjugated diene (CD), advanced oxidation protein products (AOPP), protein carbonyl (PC) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in diabetes patients when compared with normal subjects (P < 0.01). Moreover, these indexes were much higher in diabetic nephropathy than that of diabetic patients without vascular complications (P < 0.05, P < 0.01). There was a significant correlation between the serum glucose levels and PC, 8-OHdG (P < 0.05, P < 0.01). There were highly significant positive correlation of CD and MDA, AOPP and PC (P < 0.01). Plasma AOPP levels had a significant correlation with PC levels (P < 0.01). Our findings suggested that diabetes patients have more severe oxidative stress than normal persons and higher oxidative stress in diabetic nephropathy than those in patients without complications. Oxidative stress may play an important intermediary role in the pathogenesis of diabetes complications.
Literatur
1.
Zurück zum Zitat Rathmann W, Giani G (2004) Global prevalence of diabetes: estimates for the year 2000, projections for 2030. Diabetes Care 27(10):2568–2569CrossRefPubMed Rathmann W, Giani G (2004) Global prevalence of diabetes: estimates for the year 2000, projections for 2030. Diabetes Care 27(10):2568–2569CrossRefPubMed
2.
Zurück zum Zitat Giugliano D, Ceriello A (1996) Oxidative stress and diabetic vascular complications. Diabetes care 19(3):257–267CrossRefPubMed Giugliano D, Ceriello A (1996) Oxidative stress and diabetic vascular complications. Diabetes care 19(3):257–267CrossRefPubMed
3.
Zurück zum Zitat Mehrotra S, Ling KL, Bekele Y, Gerbino E, Earle KA (2001) Lipid hydroperoxide and markers of renal disease susceptibility in African–Caribbean and Caucasian patients with Type 2 diabetes mellitus. Diabet Med 18:109–115CrossRefPubMed Mehrotra S, Ling KL, Bekele Y, Gerbino E, Earle KA (2001) Lipid hydroperoxide and markers of renal disease susceptibility in African–Caribbean and Caucasian patients with Type 2 diabetes mellitus. Diabet Med 18:109–115CrossRefPubMed
4.
Zurück zum Zitat Calabrese V, Mancuso C, Sapienza M et al (2007) Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12:299–306CrossRefPubMed Calabrese V, Mancuso C, Sapienza M et al (2007) Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12:299–306CrossRefPubMed
5.
Zurück zum Zitat Kikkawa R, Koya D, Haneda M (2003) Progression of diabetic nephropathy. Am J Kidney Dis 41:S19–S21CrossRefPubMed Kikkawa R, Koya D, Haneda M (2003) Progression of diabetic nephropathy. Am J Kidney Dis 41:S19–S21CrossRefPubMed
6.
Zurück zum Zitat Suzuki S, Hinokio Y, Komatu K et al (1999) Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res Clin Pract 45:161–168CrossRefPubMed Suzuki S, Hinokio Y, Komatu K et al (1999) Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res Clin Pract 45:161–168CrossRefPubMed
7.
Zurück zum Zitat Ward PA, Till GO, Hatherill JR, Annesley TM, Kunkel RG (1985) Systemic complement activation, lung injury, and products of lipid peroxidation. J Clin Invest 76:517–527CrossRefPubMed Ward PA, Till GO, Hatherill JR, Annesley TM, Kunkel RG (1985) Systemic complement activation, lung injury, and products of lipid peroxidation. J Clin Invest 76:517–527CrossRefPubMed
8.
Zurück zum Zitat Witko-Sarsat V, Friedlander M, Capeillère-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313CrossRefPubMed Witko-Sarsat V, Friedlander M, Capeillère-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313CrossRefPubMed
9.
Zurück zum Zitat Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9CrossRefPubMed Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9CrossRefPubMed
10.
Zurück zum Zitat Signorello MG, Viviani GL, Armani U et al (2007) Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 120:607–613CrossRefPubMed Signorello MG, Viviani GL, Armani U et al (2007) Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 120:607–613CrossRefPubMed
11.
Zurück zum Zitat Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR (1996) Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 4:255–260 Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR (1996) Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 4:255–260
12.
Zurück zum Zitat Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K (2003) Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 36:557–562CrossRefPubMed Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K (2003) Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 36:557–562CrossRefPubMed
13.
Zurück zum Zitat Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W (1998) Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transpl 13:2829–2832CrossRef Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W (1998) Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transpl 13:2829–2832CrossRef
14.
Zurück zum Zitat Pan HZ, Zhang H, Chang D, Li H, Sui H (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551CrossRefPubMed Pan HZ, Zhang H, Chang D, Li H, Sui H (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551CrossRefPubMed
15.
Zurück zum Zitat Dursun E, Timur M, Dursun B, Süleymanlar G, Ozben T (2005) Protein oxidation in Type 2 diabetic patients on hemodialysis. J Diabetes Complicat 19:142–146CrossRefPubMed Dursun E, Timur M, Dursun B, Süleymanlar G, Ozben T (2005) Protein oxidation in Type 2 diabetic patients on hemodialysis. J Diabetes Complicat 19:142–146CrossRefPubMed
16.
Zurück zum Zitat Kalousová M, Skrha J, Zima T (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51:597–604PubMed Kalousová M, Skrha J, Zima T (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51:597–604PubMed
17.
Zurück zum Zitat Witko-Sarsat V, Friedlander M, Nguyen Khoa T et al (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524–2532PubMed Witko-Sarsat V, Friedlander M, Nguyen Khoa T et al (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524–2532PubMed
18.
Zurück zum Zitat Cakatay U (2005) Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31:551–557CrossRefPubMed Cakatay U (2005) Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31:551–557CrossRefPubMed
19.
Zurück zum Zitat Ramakrishna V, Jailkhani R (2007) Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diagn Pathol 2:22CrossRefPubMed Ramakrishna V, Jailkhani R (2007) Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diagn Pathol 2:22CrossRefPubMed
20.
Zurück zum Zitat Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M (2008) Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Diabetes Metab Res Rev 24:549–553CrossRefPubMed Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M (2008) Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Diabetes Metab Res Rev 24:549–553CrossRefPubMed
21.
Zurück zum Zitat Wu LL, Chiou CC, Chang PY, Wu JT (2004) Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339:1–9CrossRefPubMed Wu LL, Chiou CC, Chang PY, Wu JT (2004) Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339:1–9CrossRefPubMed
22.
Zurück zum Zitat Dandona P, Thusu K, Cook S et al (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445CrossRefPubMed Dandona P, Thusu K, Cook S et al (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445CrossRefPubMed
23.
Zurück zum Zitat Leinonen J, Lehtimäki T, Toyokuni S et al (1997) New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417:150–152CrossRefPubMed Leinonen J, Lehtimäki T, Toyokuni S et al (1997) New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417:150–152CrossRefPubMed
24.
Zurück zum Zitat Kanauchi M, Nishioka H, Hashimoto T (2002) Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 91:327–329CrossRefPubMed Kanauchi M, Nishioka H, Hashimoto T (2002) Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 91:327–329CrossRefPubMed
25.
Zurück zum Zitat Kaneto H, Fujii J, Suzuki K et al (1994) DNA cleavage induced by glycation of Cu, Zn superoxide dismutase. Biochem J 304(pt1):219–225PubMed Kaneto H, Fujii J, Suzuki K et al (1994) DNA cleavage induced by glycation of Cu, Zn superoxide dismutase. Biochem J 304(pt1):219–225PubMed
Metadaten
Titel
The oxidative stress status in diabetes mellitus and diabetic nephropathy
verfasst von
Hong-zhi Pan
Lin Zhang
Mei-yi Guo
Hong Sui
Hui Li
Wei-hua Wu
Nai-qiang Qu
Mei-hua Liang
Dong Chang
Publikationsdatum
01.12.2010
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe Sonderheft 1/2010
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0128-1

Weitere Artikel der Sonderheft 1/2010

Acta Diabetologica 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.